CMRA - Comera Life Sciences Holdings, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 9.62M
Enterprise value 8.35M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.30
Price/book (mrq)N/A
Enterprise value/revenue 8.98
Enterprise value/EBITDA -0.48

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-63.16%
S&P500 52-week change 314.65%
52-week high 35.7000
52-week low 30.3700
50-day moving average 30.6919
200-day moving average 31.2924

Share statistics

Avg vol (3-month) 315.59k
Avg vol (10-day) 317.37k
Shares outstanding 522.31M
Implied shares outstanding 6N/A
Float 89.37M
% held by insiders 151.33%
% held by institutions 12.68%
Shares short (30 May 2023) 439.18k
Short ratio (30 May 2023) 43.54
Short % of float (30 May 2023) 40.38%
Short % of shares outstanding (30 May 2023) 40.18%
Shares short (prior month 27 Apr 2023) 442.39k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-1,130.12%

Management effectiveness

Return on assets (ttm)-165.17%
Return on equity (ttm)-1,134.60%

Income statement

Revenue (ttm)930.68k
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)312.10%
Gross profit (ttm)422.71k
EBITDA -10.42M
Net income avi to common (ttm)-18.07M
Diluted EPS (ttm)-0.8500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.54M
Total cash per share (mrq)0.07
Total debt (mrq)271.17k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.72
Book value per share (mrq)-0.28

Cash flow statement

Operating cash flow (ttm)-8.81M
Levered free cash flow (ttm)-4.1M